Navigation Links
Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Date:8/19/2007

in July the enrollment of the 20th hematopoietic stem

cell transplant recipient in the company's Phase 2 trial of a DNA

vaccine against cytomegalovirus (CMV). After the 20th recipient's

two-month follow-up visit, an independent data safety monitoring board

will conduct an interim evaluation of safety data for all subjects

enrolled in the trial.

-- The company has initiated 30 of up to 60 planned clinical sites for the

AIMM (Allovectin-7(R) Immunotherapeutic for Metastatic Melanoma) Phase

3 pivotal trial of the Allovectin-7(R) cancer immunotherapeutic as

first-line therapy in chemotherapy-nave patients with recurrent Stage

III or IV metastatic melanoma. The trial is being funded by AnGes under

a collaborative agreement with Vical.

-- During the second quarter, the company completed the final contract

manufacturing and shipment of HIV vaccine bulk DNA under a $12 million

production order for the National Institutes of Health (NIH) for a

planned Phase 2b efficacy proof-of-concept trial expected to begin this

year with the support of the Partnership for AIDS Vaccine Evaluation

(PAVE). The PAVE trial will test a vaccine regimen combining a DNA

prime based on Vical's technology with an adenoviral vector boost in up

to 8,500 volunteers at sites in the United States, Africa, the

Caribbean and South America to determine its potential to prevent

infection or disease progression.

-- Vical was awarded a three-year, $6.0 million grant from the National

Institute of Allergy and Infectious Diseases (NIAID), part of the NIH,

for further development of a DNA vaccine manufacturing process with the

potential to produce several million doses of vaccines in a matter of

days. By using a cell-free manufacturing process, the company believes

that the RapidR
'/>"/>

SOURCE Vical

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
2. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
3. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
4. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
7. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
8. Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
9. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
10. Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
(Date:7/3/2015)... -- Redwood Pharma AB has entered into ... in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry Eye ... Broda technology offers many unique competitive benefits. At lower ... with low concentrations of polymer the system can be ...
(Date:7/2/2015)... July 2, 2015 Leading organizations have ... critical product and market insights in internal market ... employee-based studies, it is essential for executives to ... employees to capture critical business-related insights. ... Best Practices, LLC, most benchmarked companies find it ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... Calif., Oct. 8 Endologix, Inc. (Nasdaq: ELGX ), ... that it has become aware that Cook Medical has filed ... alleging that Endologix infringes two of Cook,s U.S. patents. , ... have just become aware of the lawsuit filed by Cook ...
... PHILADELPHIA, Oct. 8 GlaxoSmithKline (NYSE: GSK ) today ... Patent and Trademark Office (USPTO) to join the USPTO,s motion ... 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC ... United States Patent and Trademark Office). GSK and the ...
Cached Medicine Technology:Endologix Comments on Alleged Patent Infringement 2GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations 2
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national president recruitment for Regional Care, Inc. in Scottsbluff, ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the rage right now ... easily accessible, quality ingredients. Aurora Natural is proud to introduce a new line of ... fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a variety of blends ...
(Date:7/3/2015)... ... , ... First Choice Emergency Room , the largest network of independent ... new Medical Director of its Frisco facility. , “We are pleased to announce that ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Every year, ... 24-Hour Train-a-Thon where they provide members of the Red Deer community with free fitness ... day of fitness training, games, food, events and entertainment raised thousands of charity dollars ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... 4 Americans has,diabetes or is at risk for developing ... The following,release was issued today by the American Diabetes ... American Diabetes Month(R),brings to light the fastest growing health ... Americans have diabetes or are at risk of,developing type ...
... It,s linked to obesity, which then triggers hypertension, study ... kids who develop hypertension may be watching far too ... "illustrates the need for considerable physician and family involvement ... Dr. Jeffrey B. Schwimmer, associate professor of pediatrics at ...
... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ... the Company, will present at the CIBC World ... on Monday, November 5, 2007 at 3:40,p.m. ET. ... for this presentation by,visiting the "Events" section of ...
... 150+ Nursing Homes in California will simultaneously open their ... media are invited to cover the,festivities, INLAND EMPIRE, ... gypsies visit a nursing home. Nurse administrators,don,t often see ... to meet 90-year-old soldiers or 80-year-young,ballerinas! But at more ...
... 150+ Nursing Homes in California will simultaneously open their ... invited to cover the,festivities, EUREKA, Calif., Oct. 30 ... nursing home. Nurse administrators don,t often,see miniature witches and ... 90-year-old soldiers or 80-year-young ballerinas! But at more,than 150 ...
... Texas, Oct. 30 ULURU Inc. (Amex:,ULU) announced ... a voluntary,Odd-Lot Buy Back Offer, whereby the Company ... less than 100 shares of common stock. This,program ... with,stockholder recordkeeping and communications costs and the potential ...
Cached Medicine News:Health News:American Diabetes Month(R) Brings Awareness to Growing Health Care Crisis 2Health News:Too Much TV Can Raise Kids' Blood Pressure 2Health News:Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference 2Health News:Halloween Events in Southern California Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Eureka, California Bring Young and Old Together for a Ghoulish Good Time 2Health News:ULURU Inc. Announces Odd-Lot Buy Back Offer 2
The uncemented hip joint prosthesis system...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: